Influenza Antiviral Drugs Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Penetration and Dehulling Inhibitors
1.2.3 DNA Polymerase Inhibitors
1.2.4 Reverse Transcriptase Inhibitors
1.2.5 Protein Inhibitors
1.2.6 Neuraminidase Inhibitors
1.2.7 Broad-spectrum Antiviral Drugs
1.3 Market by Application
1.3.1 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza (Flu) Antiviral Drugs Market Perspective (2017-2028)
2.2 Influenza (Flu) Antiviral Drugs Growth Trends by Region
2.2.1 Influenza (Flu) Antiviral Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Influenza (Flu) Antiviral Drugs Historic Market Size by Region (2017-2022)
2.2.3 Influenza (Flu) Antiviral Drugs Forecasted Market Size by Region (2023-2028)
2.3 Influenza (Flu) Antiviral Drugs Market Dynamics
2.3.1 Influenza (Flu) Antiviral Drugs Industry Trends
2.3.2 Influenza (Flu) Antiviral Drugs Market Drivers
2.3.3 Influenza (Flu) Antiviral Drugs Market Challenges
2.3.4 Influenza (Flu) Antiviral Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza (Flu) Antiviral Drugs Players by Revenue
3.1.1 Global Top Influenza (Flu) Antiviral Drugs Players by Revenue (2017-2022)
3.1.2 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Influenza (Flu) Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza (Flu) Antiviral Drugs Revenue
3.4 Global Influenza (Flu) Antiviral Drugs Market Concentration Ratio
3.4.1 Global Influenza (Flu) Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza (Flu) Antiviral Drugs Revenue in 2021
3.5 Influenza (Flu) Antiviral Drugs Key Players Head office and Area Served
3.6 Key Players Influenza (Flu) Antiviral Drugs Product Solution and Service
3.7 Date of Enter into Influenza (Flu) Antiviral Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza (Flu) Antiviral Drugs Breakdown Data by Type
4.1 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Type (2017-2022)
4.2 Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Type (2023-2028)
5 Influenza (Flu) Antiviral Drugs Breakdown Data by Application
5.1 Global Influenza (Flu) Antiviral Drugs Historic Market Size by Application (2017-2022)
5.2 Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Influenza (Flu) Antiviral Drugs Market Size (2017-2028)
6.2 North America Influenza (Flu) Antiviral Drugs Market Size by Type
6.2.1 North America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
6.2.2 North America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028)
6.2.3 North America Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028)
6.3 North America Influenza (Flu) Antiviral Drugs Market Size by Application
6.3.1 North America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
6.3.2 North America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028)
6.3.3 North America Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028)
6.4 North America Influenza (Flu) Antiviral Drugs Market Size by Country
6.4.1 North America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022)
6.4.2 North America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Influenza (Flu) Antiviral Drugs Market Size (2017-2028)
7.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type
7.2.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
7.2.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028)
7.2.3 Europe Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028)
7.3 Europe Influenza (Flu) Antiviral Drugs Market Size by Application
7.3.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
7.3.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028)
7.3.3 Europe Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028)
7.4 Europe Influenza (Flu) Antiviral Drugs Market Size by Country
7.4.1 Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022)
7.4.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size (2017-2028)
8.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Type
8.2.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Application
8.3.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region
8.4.1 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Influenza (Flu) Antiviral Drugs Market Size (2017-2028)
9.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Type
9.2.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028)
9.3 Latin America Influenza (Flu) Antiviral Drugs Market Size by Application
9.3.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028)
9.4 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country
9.4.1 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size (2017-2028)
10.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type
10.2.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application
10.3.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country
10.4.1 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Influenza (Flu) Antiviral Drugs Introduction
11.1.4 Pfizer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Influenza (Flu) Antiviral Drugs Introduction
11.2.4 Roche Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Influenza (Flu) Antiviral Drugs Introduction
11.3.4 Sanofi Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.3.5 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Details
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Introduction
11.5.4 Merck & Co. (MSD) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.5.5 Merck & Co. (MSD) Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Influenza (Flu) Antiviral Drugs Introduction
11.6.4 Novartis Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Influenza (Flu) Antiviral Drugs Introduction
11.7.4 AbbVie Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.7.5 AbbVie Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Introduction
11.8.4 Gilead Sciences Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.8.5 Gilead Sciences Recent Developments
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Details
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.9.5 GlaxoSmithKline (GSK) Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Influenza (Flu) Antiviral Drugs Introduction
11.10.4 Amgen Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.10.5 Amgen Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Introduction
11.11.4 AstraZeneca Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.11.5 AstraZeneca Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Introduction
11.12.4 Bristol-Myers Squibb Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Introduction
11.13.4 Eli Lilly Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.13.5 Eli Lilly Recent Developments
11.14 Teva
11.14.1 Teva Company Details
11.14.2 Teva Business Overview
11.14.3 Teva Influenza (Flu) Antiviral Drugs Introduction
11.14.4 Teva Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.14.5 Teva Recent Developments
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Influenza (Flu) Antiviral Drugs Introduction
11.15.4 Bayer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.15.5 Bayer Recent Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Introduction
11.16.4 Novo Nordisk Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.16.5 Novo Nordisk Recent Developments
11.17 Allergan
11.17.1 Allergan Company Details
11.17.2 Allergan Business Overview
11.17.3 Allergan Influenza (Flu) Antiviral Drugs Introduction
11.17.4 Allergan Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.17.5 Allergan Recent Developments
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Influenza (Flu) Antiviral Drugs Introduction
11.18.4 Takeda Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.18.5 Takeda Recent Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Details
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Introduction
11.19.4 Boehringer Ingelheim Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022)
11.19.5 Boehringer Ingelheim Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Penetration and Dehulling Inhibitors
Table 3. Key Players of DNA Polymerase Inhibitors
Table 4. Key Players of Reverse Transcriptase Inhibitors
Table 5. Key Players of Protein Inhibitors
Table 6. Key Players of Neuraminidase Inhibitors
Table 7. Key Players of Broad-spectrum Antiviral Drugs
Table 8. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Influenza (Flu) Antiviral Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Influenza (Flu) Antiviral Drugs Market Share by Region (2017-2022)
Table 12. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Influenza (Flu) Antiviral Drugs Market Share by Region (2023-2028)
Table 14. Influenza (Flu) Antiviral Drugs Market Trends
Table 15. Influenza (Flu) Antiviral Drugs Market Drivers
Table 16. Influenza (Flu) Antiviral Drugs Market Challenges
Table 17. Influenza (Flu) Antiviral Drugs Market Restraints
Table 18. Global Influenza (Flu) Antiviral Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Influenza (Flu) Antiviral Drugs Revenue Share by Players (2017-2022)
Table 20. Global Top Influenza (Flu) Antiviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2021)
Table 21. Ranking of Global Top Influenza (Flu) Antiviral Drugs Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Influenza (Flu) Antiviral Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Influenza (Flu) Antiviral Drugs Product Solution and Service
Table 25. Date of Enter into Influenza (Flu) Antiviral Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2017-2022)
Table 29. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Type (2023-2028)
Table 31. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Influenza (Flu) Antiviral Drugs Revenue Share by Application (2017-2022)
Table 33. Global Influenza (Flu) Antiviral Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Influenza (Flu) Antiviral Drugs Revenue Share by Application (2023-2028)
Table 35. North America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Influenza (Flu) Antiviral Drugs Product
Table 68. Pfizer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Influenza (Flu) Antiviral Drugs Product
Table 73. Roche Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 74. Roche Recent Developments
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Influenza (Flu) Antiviral Drugs Product
Table 78. Sanofi Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 79. Sanofi Recent Developments
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Influenza (Flu) Antiviral Drugs Product
Table 83. Johnson & Johnson Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 84. Johnson & Johnson Recent Developments
Table 85. Merck & Co. (MSD) Company Details
Table 86. Merck & Co. (MSD) Business Overview
Table 87. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Product
Table 88. Merck & Co. (MSD) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 89. Merck & Co. (MSD) Recent Developments
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Influenza (Flu) Antiviral Drugs Product
Table 93. Novartis Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 94. Novartis Recent Developments
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Influenza (Flu) Antiviral Drugs Product
Table 98. AbbVie Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 99. AbbVie Recent Developments
Table 100. Gilead Sciences Company Details
Table 101. Gilead Sciences Business Overview
Table 102. Gilead Sciences Influenza (Flu) Antiviral Drugs Product
Table 103. Gilead Sciences Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 104. Gilead Sciences Recent Developments
Table 105. GlaxoSmithKline (GSK) Company Details
Table 106. GlaxoSmithKline (GSK) Business Overview
Table 107. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product
Table 108. GlaxoSmithKline (GSK) Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 109. GlaxoSmithKline (GSK) Recent Developments
Table 110. Amgen Company Details
Table 111. Amgen Business Overview
Table 112. Amgen Influenza (Flu) Antiviral Drugs Product
Table 113. Amgen Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 114. Amgen Recent Developments
Table 115. AstraZeneca Company Details
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca Influenza (Flu) Antiviral Drugs Product
Table 118. AstraZeneca Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 119. AstraZeneca Recent Developments
Table 120. Bristol-Myers Squibb Company Details
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product
Table 123. Bristol-Myers Squibb Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 124. Bristol-Myers Squibb Recent Developments
Table 125. Eli Lilly Company Details
Table 126. Eli Lilly Business Overview
Table 127. Eli Lilly Influenza (Flu) Antiviral Drugs Product
Table 128. Eli Lilly Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 129. Eli Lilly Recent Developments
Table 130. Teva Company Details
Table 131. Teva Business Overview
Table 132. Teva Influenza (Flu) Antiviral Drugs Product
Table 133. Teva Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 134. Teva Recent Developments
Table 135. Bayer Company Details
Table 136. Bayer Business Overview
Table 137. Bayer Influenza (Flu) Antiviral Drugs Product
Table 138. Bayer Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 139. Bayer Recent Developments
Table 140. Novo Nordisk Company Details
Table 141. Novo Nordisk Business Overview
Table 142. Novo Nordisk Influenza (Flu) Antiviral Drugs Product
Table 143. Novo Nordisk Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 144. Novo Nordisk Recent Developments
Table 145. Allergan Company Details
Table 146. Allergan Business Overview
Table 147. Allergan Influenza (Flu) Antiviral Drugs Product
Table 148. Allergan Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 149. Allergan Recent Developments
Table 150. Takeda Company Details
Table 151. Takeda Business Overview
Table 152. Takeda Influenza (Flu) Antiviral Drugs Product
Table 153. Takeda Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 154. Takeda Recent Developments
Table 155. Boehringer Ingelheim Company Details
Table 156. Boehringer Ingelheim Business Overview
Table 157. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product
Table 158. Boehringer Ingelheim Revenue in Influenza (Flu) Antiviral Drugs Business (2017-2022) & (US$ Million)
Table 159. Boehringer Ingelheim Recent Developments
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza (Flu) Antiviral Drugs Market Share by Type: 2021 VS 2028
Figure 2. Penetration and Dehulling Inhibitors Features
Figure 3. DNA Polymerase Inhibitors Features
Figure 4. Reverse Transcriptase Inhibitors Features
Figure 5. Protein Inhibitors Features
Figure 6. Neuraminidase Inhibitors Features
Figure 7. Broad-spectrum Antiviral Drugs Features
Figure 8. Global Influenza (Flu) Antiviral Drugs Market Share by Application: 2021 VS 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Household Case Studies
Figure 12. Others Case Studies
Figure 13. Influenza (Flu) Antiviral Drugs Report Years Considered
Figure 14. Global Influenza (Flu) Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Influenza (Flu) Antiviral Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Influenza (Flu) Antiviral Drugs Market Share by Region: 2021 VS 2028
Figure 17. Global Influenza (Flu) Antiviral Drugs Market Share by Players in 2021
Figure 18. Global Top Influenza (Flu) Antiviral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza (Flu) Antiviral Drugs as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Influenza (Flu) Antiviral Drugs Revenue in 2021
Figure 20. North America Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028)
Figure 22. North America Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028)
Figure 23. North America Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028)
Figure 24. United States Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028)
Figure 28. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028)
Figure 29. Europe Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028)
Figure 30. Germany Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Influenza (Flu) Antiviral Drugs Market Size Share by Region (2017-2028)
Figure 40. China Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028)
Figure 50. Mexico Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Influenza (Flu) Antiviral Drugs Market Size Share by Country (2017-2028)
Figure 56. Turkey Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Influenza (Flu) Antiviral Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 61. Sanofi Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 62. Johnson & Johnson Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 63. Merck & Co. (MSD) Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 65. AbbVie Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 66. Gilead Sciences Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 67. GlaxoSmithKline (GSK) Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 68. Amgen Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 69. AstraZeneca Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 71. Eli Lilly Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 72. Teva Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 73. Bayer Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 74. Novo Nordisk Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 75. Allergan Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 76. Takeda Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 77. Boehringer Ingelheim Revenue Growth Rate in Influenza (Flu) Antiviral Drugs Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Industry Market Size
